Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study ; day:27 ; month:10 ; year:2021 ; pages:1-11
Breast cancer research and treatment ; (27.10.2021), 1-11
- Urheber
-
Schreiber, Anna R.
Kagihara, Jodi
Eguchi, Megan
Kabos, Peter
Fisher, Christine M.
Meyer, Elisabeth
Molina, Elizabeth
Kondapalli, Lavanya
Bradley, Cathy J.
Diamond, Jennifer R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-021-06424-z
- URN
-
urn:nbn:de:101:1-2022010720010775884930
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schreiber, Anna R.
- Kagihara, Jodi
- Eguchi, Megan
- Kabos, Peter
- Fisher, Christine M.
- Meyer, Elisabeth
- Molina, Elizabeth
- Kondapalli, Lavanya
- Bradley, Cathy J.
- Diamond, Jennifer R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Real-world data of HER2-negative early breast cancer patients treated with anthracycline and/or taxane regimens in Japan
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study
Taxane-Induced Upper Gastrointestinal Bleeding
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
New Taxane Diterpenoids from Taxus yunnanensis
Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbine
Combined homologous recombination repair deficiency and immune activation analysis for predicting intensified responses of anthracycline, cyclophosphamide and taxane chemotherapy in triple-negative breast cancer
A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
Studien zu Synthesekonzepten zum Aufbau funktionalisierter Taxane
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17)
Upfront taxane could be superior to pegylated liposomal doxorubicin (PLD): a retrospective real-world analysis of treatment sequence taxane–PLD versus PLD–taxane in patients with metastatic breast cancer
Real-world data of HER2-negative early breast cancer patients treated with anthracycline and/or taxane regimens in Japan
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study
Taxane-Induced Upper Gastrointestinal Bleeding
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
New Taxane Diterpenoids from Taxus yunnanensis
Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbine
Combined homologous recombination repair deficiency and immune activation analysis for predicting intensified responses of anthracycline, cyclophosphamide and taxane chemotherapy in triple-negative breast cancer
A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
Studien zu Synthesekonzepten zum Aufbau funktionalisierter Taxane
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17)
Upfront taxane could be superior to pegylated liposomal doxorubicin (PLD): a retrospective real-world analysis of treatment sequence taxane–PLD versus PLD–taxane in patients with metastatic breast cancer
Real-world data of HER2-negative early breast cancer patients treated with anthracycline and/or taxane regimens in Japan
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study
Taxane-Induced Upper Gastrointestinal Bleeding
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
New Taxane Diterpenoids from Taxus yunnanensis
Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbine
Combined homologous recombination repair deficiency and immune activation analysis for predicting intensified responses of anthracycline, cyclophosphamide and taxane chemotherapy in triple-negative breast cancer
A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
Studien zu Synthesekonzepten zum Aufbau funktionalisierter Taxane
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17)